Oriole advises TyraTech in successful $17.5 million sale of Vamousse®


Oriole Advisors, LLC is pleased to announce that Vamousse®, TyraTech Inc.’s multinational brand of lice control products, has been acquired by Alliance Pharma.  

The transaction closed on December 28, 2017.  Oriole Advisors acted as the exclusive financial advisor to TyraTech. Alliance paid an initial consideration of $13 million and deferred contingent consideration of up to $4.5 million.

TyraTech develops insect and parasite products that do not rely on traditional pesticides.  Vamousse was launched in the UK and US in 2014, posting net sales in the year to December 31 2016 of $6.6 million with gross profit of $4.6 million. Most of its revenue, 83%, comes from the US with the rest from the UK.

Oriole Advisors, an independent Atlanta-based advisory firm, focuses on providing M&A services to leading small- and middle-market companies and private equity firms. Oriole also assists companies with raising capital for growth, acquisitions, recapitalization, going-private and management buy-out transactions, and provides strategic advisory services. The professionals at Oriole have transaction experience across a broad range of healthcare sectors.